Navigation Links
Baby Eva Named After Pioneering IVF Test
Date:6/13/2013

MENLO PARK, California, June 14, 2013 /PRNewswire/ --

Auxogyn announces the birth of the first baby in Scotland to be born using a ground-breaking new approach to IVF, the 'Early Embryo Viability Assessment' (Eeva) test, that improves embryo selection.

Video  and photos available at 10am BST

Scotland is welcoming Baby Eva today, the world's first baby to be born and named by her parents after the new Eeva test. Eva was born on 11th June following Susan Walker-Dempster and David Dempster's hardship of trying to build a family together. Susan and David chose to have the Eeva test at the GCRM to increase their chances of IVF success. The new mother, Susan said "we wanted every chance to be successful, so we chose Eeva."

The Eeva test uses unique predictive software in combination with a time-lapse analysis technique to automatically analyse embryo development against scientifically and clinically validated cell-division parameters. The test aids embryologists in selecting the most viable embryos for transfer, potentially increasing the chances of a successful IVF cycle.

"We are delighted to hear the news of this healthy birth and wish the family the very best," said Lissa Goldenstein, President and CEO of Auxogyn.  "The Eeva test has been developed to give IVF clinicians objective information about the embryo and provide insight into its growth potential. With more couples choosing to use Eeva, we are looking forward to many more births like Baby Eva today."

Scientist Professor Richard Fleming at GCRM said: "We are very proud to be among the first clinics in the world to announce this news as it demonstrates how successful this new technology can be in enabling couples to have a higher chance of conceiving a baby with IVF. GCRM has always strived to be one of the leading IVF Centres in Europe, offering couples the latest innovations and best possible outcomes. The Eeva test is the practical end point of good quality research and is the start of a new chapter in the evolution of IVF."

About IVF

Infertility affects one out of every 6 couples and about 7.3 million women and their partners in the U.S..The demand for assisted reproduction tools and procedures is growing worldwide. This growth is occurring despite the significant cost per IVF cycle and the low success rate, with approximately one-third of cycles resulting in a live birth. This necessitates the transfer of multiple embryos and/or conducting multiple cycles, leading to greater physical, emotional, practical and financial costs, before determining if pregnancy can be achieved.

About the Early Embryo Viability Assessment (Eeva) Test

The Eeva test provides IVF clinicians with predictive information about the embryo's development potential to help improve embryo selection. Eeva's proprietary software automatically analyzes embryo development against scientifically and clinically validated cell-division parameters conceived by researchers at Stanford University in the US. With results from the Eeva test, IVF teams now have predictive and objective information to combine morphological assessment to help improve the embryo selection decision. The Eeva Test was validated in a prospective, multi-centre, 54-patient clinical trial with 758 embryos. Embryologists using Eeva were significantly able to improve their ability to identify non-viable embryos relative to traditional methods alone. Additionally, Eeva was able to increase the consistency of embryo assessment across embryologists. Results of this study were presented in July 2012 at the European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting and published by Conaghan et al in Fertility and Sterility, May 2013.

Eeva is currently CE Marked and available for use in the EU and is pending FDA clearance in the United States. For a full list of clinics offering the Eeva test pleasevisithttp://www.eevaivf.com  or follow us on Twitter @EevaIVF.

About Auxogyn

Auxogyn is revolutionising the field of reproductive medicine by translating scientific discoveries in early embryo development into clinical tools. The Company's flagship product, the Eeva™ Test, delivers consistent, objective information regarding embryo viability that IVF clinicians and patients can use to make important treatment decisions. Auxogyn is privately held and funded by Kleiner Perkins Caufield & Byers, Merck Serono Ventures, SR One and TPG Biotech. For more information visit http://www.auxogyn.com  and follow us on Twitter @Auxogyn.


Media contacts:

Sylvie Berrebi :sylvie@sciad.com  +44-(0)-7795-197271.


'/>"/>
SOURCE Auxogyn
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Comprehensive Care Corporation CEO Clark A. Marcus Named to Board of Americas Agenda: Health Care for All
2. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
3. Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year
4. RenovoRx Named Winner of 2013 TiE50 "Top Startup"
5. Wyle Aided System Gets Named to Space Technology Hall of Fame
6. Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology
7. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
8. Bayer Employee Named Rising Star by Healthcare Businesswomens Association
9. Shelia Barchuk Named a VIP Member of Worldwide Whos Who for Excellence in Business Management
10. Inaugural Denton A. Cooley Fellow of Surgical Innovation named at Texas Childrens Hospital
11. Henry Schein Named As One Of FORTUNEs Largest 300 Corporations In America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2020)... ... 12, 2020 , ... FutuRx, Israel’s leading biopharmaceutical incubator, a ... Ventures, Inc, operating under a tender from the Israeli Innovation Authority (IIA) has ... at Tel-Aviv University and Glasgow University. , Epeius pharma develops next generation ...
(Date:1/10/2020)... ... January 10, 2020 , ... Reach ... Counselor Association, will celebrate high school counselors and award the first annual Excellence ... National Championship weekend and Extra Yard for Teachers Summit celebration on Saturday, January ...
(Date:1/10/2020)... ... 2020 , ... By mid-January, many people’s New Year’s resolutions have fallen by the wayside. ... Night Wellness Retreat for the 2020 season. , Open each year from the last spring ... in May and the first weekend of October. The new dates for New Life Hiking ...
Breaking Medicine Technology:
(Date:1/23/2020)... ... ... SignatureCare Emergency Center is set to expand to North Dallas with the opening of ... of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, the new location will ... It will serve residents and businesses around Lewisville, TX, including Double Oak, Copper Canyon, ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... Let’s face ... dynamics came out strongly. Old family issues, rivalries, and secrets were revisited. It’s easy ... many of those coping with addiction and their families, the holidays posed additional stress ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... adults living with memory impairment, has announced the Best Memory Care Facilities in ... to experts, facility features and amenities. , According to the Alzheimer’s ...
(Date:1/23/2020)... ... , ... Dr. Dan Myers and The Dentist Centers Sandy Springs are thrilled ... dental staff. The Dentist Centers is a state-of-the-art family practice, offering a ... restorative dentistry, all in a relaxing, comfortable environment. , As a new addition to ...
(Date:1/23/2020)... ... January 23, 2020 , ... The Incentive ... IRF Board of Trustees. Representing all segments of the incentives, rewards, and recognition ... of conducting research and providing education highlighting the power of incentive and motivational ...
Breaking Medicine News(10 mins):